This website will be unavailable from Thursday, May 30, 2024 at 6:00 p.m. through Monday, June 3, 2024 at 7:00 a.m. due to data center maintenance.


 
Bill:  HB 562 
Legislative Session: 86(R) Council Document: 86R 4203 JSC-D
Add to Bill List
Last Action:05/01/2019 H Committee report sent to Calendars
Caption Version:House Committee Report
Caption Text:Relating to warning labels for opioid prescription drugs.
Author:Thierry
Coauthor:Cortez
Subjects:Alcoholism & Drug Abuse (I0030)
Health--Other Diseases & Medical Conditions (I0383)
MEDICINE & PRESCRIPTION DRUGS (S7338)
PACKAGING & LABELING REQUIREMENTS (S0339)
PHARMACIES & PHARMACISTS (S1192)
PHARMACY, TEXAS STATE BOARD OF (V0022)
House Committee:Public Health
Status:Out of committee
Vote:Ayes=9   Nays=0   Present Not Voting=0   Absent=2
Actions: (descending date order)
Description Comment Date       Time       Journal Page
H   Committee report sent to Calendars      05/01/2019    
H   Committee report distributed      05/01/2019   08:15 AM 
H   Comte report filed with Committee Coordinator      04/30/2019     2646
H   Reported favorably as substituted      04/29/2019    
H   Committee substitute considered in committee      04/29/2019    
H   Considered in formal meeting      04/29/2019    
H   Left pending in committee      04/24/2019    
H   Testimony taken/registration(s) recorded in committee      04/24/2019    
H   Committee substitute considered in committee      04/24/2019    
H   Considered in public hearing      04/24/2019    
H   Scheduled for public hearing on . . .      04/24/2019    
H   Referred to Public Health      02/20/2019   12:02 PM  368
H   Read first time      02/20/2019     368
H   Filed      12/18/2018